Endometrial cancer has about 6-fold lower GPER mRNA expression than normal endometrium, and G-1 treatment slowed the growth of the GPER-positive cell lines but had no effect on a GPER-negative cell line [167]. This evidence concerns the gene GPER1 and endometrial cancer.